Stem Cell Market Growth, Challenges, and Opportunities to 2028
The global induced pluripotent stem cells (iPSCs) market is poised for significant growth, projected to increase from $3.4 billion...
Jon Napitupulu
Rlyb212 Dosing in Pregnant Women: Target-Mediated Drug Disposition
Rallybio Corporation published a manuscript detailing a novel model for determining drug dosage in pregnant women, specifically for their...
ImmunoTech Announces Cash Conservation Plan
AIM ImmunoTech Inc. has launched a cash conservation plan to support its clinical trials and drug development, particularly for...
FDA Approves Rapiblyktm for Atrial Fibrillation and Flutter
The FDA has approved Rapiblyk (landiolol), an ultra-short-acting beta-blocker, for the short-term treatment of supraventricular tachycardia (SVT), including atrial...
EU Approves Tevimbra for Esophageal and Gastric Cancer
The European Commission approved BeiGene’s tislelizumab (TEVIMBRA), combined with chemotherapy, for first-line treatment of esophageal squamous cell carcinoma (ESCC)...
Acadia Gets Exclusive Saniona San711 License
Acadia Pharmaceuticals has licensed SAN711, a first-in-class drug, from Saniona for global development and commercialization. The drug is targeted...
Arrowhead Pharmaceuticals Reports Strong 2024 Fiscal Year-End Results
Arrowhead Pharmaceuticals announced its financial results for the 2024 fiscal year, highlighting the submission of its first New Drug...
Claudin 18.2 Targeted Therapy Market Forecast 2024-2029
Claudin 18.2, a protein typically found in tight junctions, has emerged as a promising therapeutic target for various cancers,...
Eyoni LCS: AI Lung Cancer Diagnostics at RSNA 2024
Median Technologies, a developer of AI-powered medical imaging software, will present its latest advancements at the 2024 Radiological Society...
Lung Cancer Therapy Market 2023-2029: $70.39 Billion Analysis & Growth
The global lung cancer therapy market, valued at $32.50 billion in 2023, is projected to reach $70.39 billion by...